Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Lazzeri

Showing results (291-300 of 327) with videos related to

Pageof 33
Sort By:
BJU International|August 19, 2014
Clinical performance of the Prostate Health Index (PHI) for the prediction of prostate cancer in obese men: data from the PROMEtheuS project, a multicentre European prospective studyAlberto Abrate, Massimo Lazzeri, Giovanni Lughezzani, et al.
The Journal of Urology|February 8, 2018
<sup>68</sup>Ga-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational StudyEgesta Lopci, Alberto Saita, Massimo Lazzeri, et al.
Urologic Oncology|August 1, 2025
Assessing oncological outcomes of bladder-sparing treatments in patients with BCG-unresponsive and BCG-exposed non-muscle-invasive bladder cancerAndrea Piccolini, Roberto Contieri, Alessandro Uleri, et al.
European Journal of Hybrid Imaging|May 22, 2018
Targeted 11C-choline PET-CT/TRUS software fusion-guided prostate biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsyMassimo Lazzeri, Egesta Lopci, Giovanni Lughezzani, et al.
World Journal of Urology|November 7, 2019
Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) projectRodolfo Hurle, Paolo Casale, Alberto Saita, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|March 23, 2021
Oncology and complicationsGiuseppe Giordano, Evangelia Kyriazi, Charalampos Mavridis, et al.
Diagnostics (Basel, Switzerland)|March 13, 2024
A Comparative Evaluation of Multiparametric Magnetic Resonance Imaging and Micro-Ultrasound for the Detection of Clinically Significant Prostate Cancer in Patients with Prior Negative BiopsiesEdoardo Beatrici, Nicola Frego, Giuseppe Chiarelli, et al.
European Urology Open Science|September 24, 2024
A Propensity Score-matched Comparison of Micro-ultrasound-guided Transrectal and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion-guided Transperineal Prostate Biopsies for Detection of Clinically Significant Prostate CancerAndrea Piccolini, Pier Paolo Avolio, Cesare Saitta, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 28, 2021
Hope for Ostomates: A Carbon and Zeolite Impregnated Polyester Fabric Inhibits Urine Odor in Cancer Patients: A Randomized Experimental StudyGianluigi Taverna, Linda M Thiel, Desiree L Miller, et al.
BJUI Compass|October 11, 2023
Male awareness of prostate cancer risk remains poor in relatives of women with germline variants in DNA-repair genesVittorio Fasulo, NicolòMaria Buffi, Giuseppe Chiarelli, et al.
Pageof 33

Showing results (291-300 of 327) with videos related to

Sort By:
Pageof 33
BJU International|August 19, 2014
Clinical performance of the Prostate Health Index (PHI) for the prediction of prostate cancer in obese men: data from the PROMEtheuS project, a multicentre European prospective studyAlberto Abrate, Massimo Lazzeri, Giovanni Lughezzani, et al.
The Journal of Urology|February 8, 2018
<sup>68</sup>Ga-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational StudyEgesta Lopci, Alberto Saita, Massimo Lazzeri, et al.
Urologic Oncology|August 1, 2025
Assessing oncological outcomes of bladder-sparing treatments in patients with BCG-unresponsive and BCG-exposed non-muscle-invasive bladder cancerAndrea Piccolini, Roberto Contieri, Alessandro Uleri, et al.
European Journal of Hybrid Imaging|May 22, 2018
Targeted 11C-choline PET-CT/TRUS software fusion-guided prostate biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsyMassimo Lazzeri, Egesta Lopci, Giovanni Lughezzani, et al.
World Journal of Urology|November 7, 2019
Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) projectRodolfo Hurle, Paolo Casale, Alberto Saita, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|March 23, 2021
Oncology and complicationsGiuseppe Giordano, Evangelia Kyriazi, Charalampos Mavridis, et al.
Diagnostics (Basel, Switzerland)|March 13, 2024
A Comparative Evaluation of Multiparametric Magnetic Resonance Imaging and Micro-Ultrasound for the Detection of Clinically Significant Prostate Cancer in Patients with Prior Negative BiopsiesEdoardo Beatrici, Nicola Frego, Giuseppe Chiarelli, et al.
European Urology Open Science|September 24, 2024
A Propensity Score-matched Comparison of Micro-ultrasound-guided Transrectal and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion-guided Transperineal Prostate Biopsies for Detection of Clinically Significant Prostate CancerAndrea Piccolini, Pier Paolo Avolio, Cesare Saitta, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 28, 2021
Hope for Ostomates: A Carbon and Zeolite Impregnated Polyester Fabric Inhibits Urine Odor in Cancer Patients: A Randomized Experimental StudyGianluigi Taverna, Linda M Thiel, Desiree L Miller, et al.
BJUI Compass|October 11, 2023
Male awareness of prostate cancer risk remains poor in relatives of women with germline variants in DNA-repair genesVittorio Fasulo, NicolòMaria Buffi, Giuseppe Chiarelli, et al.
Pageof 33